1. Home
  2. AWRE vs INTS Comparison

AWRE vs INTS Comparison

Compare AWRE & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$2.04

Market Cap

44.5M

Sector

Technology

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
INTS
Founded
1986
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
24.0M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
AWRE
INTS
Price
$2.04
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.33
AVG Volume (30 Days)
27.5K
3.2M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
N/A
52 Week Low
$1.37
$0.19
52 Week High
$2.95
$3.17

Technical Indicators

Market Signals
Indicator
AWRE
INTS
Relative Strength Index (RSI) 39.53 47.55
Support Level $2.06 $0.40
Resistance Level $2.17 $0.46
Average True Range (ATR) 0.11 0.06
MACD 0.00 -0.01
Stochastic Oscillator 18.42 23.78

Price Performance

Historical Comparison
AWRE
INTS

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: